Coartem

GPTKB entity

Statements (58)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:bfsLayer 6
gptkbp:bfsParent gptkb:artemether
gptkbp:activities inhibits parasite growth
artemisinin derivative
gptkbp:age adults
children over 5 kg
gptkbp:approves gptkb:2001
gptkb:World_Health_Organization
gptkbp:availability prescription only
gptkbp:category gptkb:C
gptkbp:clinical_trial extensively studied
first-line treatment in many countries
gptkbp:contains gptkb:artemether
gptkb:lumefantrine
gptkbp:contraindication hypersensitivity to artemether or lumefantrine
gptkbp:distribution widely used in endemic areas
gptkbp:dosage_form fixed-dose combination
based on body weight
gptkbp:duration 3 days
gptkbp:education inform about potential side effects
advise on adherence to regimen
gptkbp:excretion primarily through feces
some renal excretion
gptkbp:form tablets
suspension
oral tablet
gptkbp:formulation combination therapy
gptkbp:healthcare important in malaria control efforts
https://www.w3.org/2000/01/rdf-schema#label Coartem
gptkbp:impact significantly reduced malaria mortality
gptkbp:interacts_with may interact with certain antiretroviral drugs
may interact with some anticonvulsants
gptkbp:invention patented
gptkbp:is_effective_against high against Plasmodium falciparum
effective in uncomplicated malaria
gptkbp:is_monitored_by requires monitoring of heart rate
gptkbp:is_used_for treatment of malaria
gptkbp:latest_version gptkb:stock_market_index
gptkbp:lifespan approximately 3 days
gptkbp:marketed_as gptkb:Novartis
gptkbp:partnerships collaborates with health organizations
gptkbp:pharmacokinetics included
metabolized in the liver
rapid absorption
gptkbp:price varies by region
gptkbp:provides_information_on recommended by WHO
gptkbp:research ongoing studies for new formulations
gptkbp:safety_features generally well tolerated
gptkbp:shelf_life 24 months
gptkbp:side_effect fatigue
headache
nausea
vomiting
rarely causes severe reactions
gptkbp:storage store below 30° C
gptkbp:treatment low in endemic regions
gptkbp:water_resistance limited resistance reported